For centuries, the field of pathology has been defined by a single instrument: the microscope. But according to William ...

Infectious outbreaks or antimicrobial resistance are often labelled as global health crises. Yet a quieter crisis has been ...

Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...

Japanese golf legend Masashi Ozaki died at 78 after battling stage 4 sigmoid colon cancer. The disease develops in the lower ...

Scientists at Children's Medical Center Research Institute at UT Southwestern (CRI) have discovered a benefit of vitamin C ...

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...

In part due to research by two University of Michigan researchers, a form of leukemia can be treated more easily through an FDA-approved drug.

Cancer is no longer considered untreatable, yet improving the accuracy and timeliness of diagnostics and treatment remains ...

The incidence of early-onset colorectal cancer has been increasing worldwide, a trend that has coincided with growing intake ...

Aiforia has signed an agreement with a world-renowned cancer institute in the United States to collaborate on AI-powered image analysis. The collaboration includes the use of the Aiforia’s AI training ...

The Swedish Childhood Cancer Foundation (Barncancerfonden) has granted SEK 35,3 million to KI for childhood cancer research. This year, the Foundation ...

“PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility,” by Astellas Pharma Inc. News release; Dec. 17, 2025.